This compound is primarily utilized in the field of cancer research due to its role as a potent inhibitor of specific protein-protein interactions. It targets the menin-MLL interaction, which is crucial in the development of certain types of leukemia. By disrupting this interaction, it shows potential in halting the progression of leukemia cells, making it a valuable tool in studying therapeutic strategies for MLL-rearranged leukemias. Its application extends to preclinical studies where it aids in understanding the molecular mechanisms underlying cancer and in the development of targeted cancer therapies.